17 October 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics finds an increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes.
The impact of diabetes for hepatocellular carcinoma (HCC) development in chronic hepatitis C pati
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors